Owlet, Inc. (OWLT) came out with quarterly earnings of $0.03 per share, beating the Zacks Consensus Estimate of a loss of $0.23 per share. This compares to earnings of $0.03 per share a year ago.
Owlet (OWLT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Owlet, Inc. remains a buy as it evolves into a comprehensive pediatric health platform and consistently beats and raises revenue guidance. OWLT demonstrates strong revenue growth, improving operating leverage, and expanding high-margin subscription offerings, despite ongoing operating losses and tariff headwinds. Key growth catalysts include Owlet 360 subscriber expansion, BabySat healthcare partnerships, and a telehealth pilot, with international growth still in early stages.
Owlet, Inc.(NYSE:OWLT ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Amanda Twede Crawford - Chief Financial Officer Jay Gentzkow - Vice President of Investor Relations Jonathan Harris - President Kurt Workman - Co-Founder, CEO & Director Conference Call Participants Alex Joseph Fuhrman - Lucid Capital Markets, LLC, Research Division Benjamin Charles Haynor - Lake Street Capital Markets, LLC, Research Division Boris Peaker - Unidentified Company Charles Rhyee - TD Cowen, Research Division Owen Ray Rickert - Northland Capital Markets, Research Division Operator Good afternoon. Thank you for attending today's Owlet Q2 '25 Earnings Conference Call.
Owlet, Inc. (OWLT) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.21. This compares to break-even earnings per share a year ago.
Owlet has rebounded from FDA-related setbacks, regaining approval and showing strong revenue growth, with new revenue highs and improved margins in 2024. Key growth drivers include FDA-cleared products, the new Owlet 360 subscription, international expansion, and healthcare partnerships, all supporting revenue. Risks remain with high SG&A costs, customer concentration, dilution, and regulatory uncertainties, but profitability is expected as the company scales.
Owlet, Inc. (NYSE:OWLT ) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ET Company Participants Jay Gentzkow - Vice President, Investor Relations Kurt Workman - Co-Founder & Chief Executive Officer Jonathan Harris - President & Chief Revenue Officer Amanda Twede Crawford - Chief Financial Officer Conference Call Participants Lucas Romanski - TD Cowen Colin Ricker - Northland Capital Ben Haynor - Lake Street Capital Markets Operator Good Afternoon, and thank you all for attending the Owlet Q1 2025 Earnings Conference Call. My name is Brika and I will be your moderator for today.
Owlet, Inc. (NYSE:OWLT ) Q4 2024 Earnings Conference Call March 4, 2025 4:30 PM ET Company Participants Jay Gentzkow - Vice President, Investor Relations Kurt Workman - Co-Founder & Chief Executive Officer Jonathan Harris - President & Chief Revenue Officer Amanda Twede Crawford - Chief Financial Officer Conference Call Participants Operator Good afternoon. Thank you for attending the Owlet Fourth Quarter 2024 Earnings Conference Call.
Owlet, Inc. (NYSE:OWLT ) Q3 2024 Earnings Conference Call November 13, 2024 4:30 PM ET Company Participants Jay Gentzkow - Vice President of Investor Relations Kurt Workman - CEO & Co-Founder Jonathan Harris - President and Chief Revenue Officer Amanda Twede Crawford - Chief Financial Officer Conference Call Participants Operator Thank you for standing by and good afternoon. Thank you for attending today's Owlet's Q3 '24 Financial Results Conference Call.
NEW YORK CITY, NY / ACCESSWIRE / September 11, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sandbridge Acquisition Corporation ("Sandbridge"), which merged with Owlet, Inc. ("Owlet") (NYSE: OWLT) on July 15, 2021. Investors who purchased Sandbridge shares prior to June 1, 2021, and continue to hold Owlet shares to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/OWLT.
NEW YORK CITY, NY / ACCESSWIRE / September 10, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sandbridge Acquisition Corporation ("Sandbridge"), which merged with Owlet, Inc. ("Owlet") (NYSE: OWLT) on July 15, 2021. Investors who purchased Sandbridge shares prior to June 1, 2021, and continue to hold Owlet shares to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/OWLT.
NEW YORK CITY, NY / ACCESSWIRE / September 9, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sandbridge Acquisition Corporation ("Sandbridge"), which merged with Owlet, Inc. ("Owlet") (NYSE: OWLT) on July 15, 2021. Investors who purchased Sandbridge shares prior to June 1, 2021, and continue to hold Owlet shares to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/OWLT.